Baylor College of Medicine

A Randomized Controlled Open-Label Study of CM4620 Injectable Emulsion in Patients with Severe COVID-19 Pneumonia (H-477226)

Description

Content

In this clinical trial, we are enrolling patients who present to our Emergency Department with sever COVID-19 pneumonia. This is an open-label randomized controlled study to evaluate the safety, efficacy, and the pharmacokinetic profile of CM4620-IE in patients who meet the enrollment criteria.

Contact

EM Research Team

Phone 1: 713–873–9818

IRB: H-477226

Status:

Active

Created:

Back to topback-to-top